Saturday 25 February 2012

National Institutes Of Health-Birth Control Pills-Contraceptive Drugs-Health Regulators

FDA favors more risk info on birth control pills

Federal health regulators are leaning toward adding new information about the risk of blood clots to the labels of widely prescribed Birth Control pills such as Yaz, in light of growing evidence that the newer contraceptive drugs may be riskier than older drugs. read more..


Active Surveillance May Benefit Men With Low-Risk Prostate Cancer

WEDNESDAY, Dec. 7 (Healthday News) -- As more men are screened for and diagnosed with low-risk prostate cancer, a new draft report released Wednesday by a U.S. National Institutes of Health panel concluded that research on the safety of "active surveillance" is needed. read more..

No comments:

Post a Comment